Brief: Nymox Pharmaceutical- Main Delayed Vendor Documentation That Was Incomplete Has Been Accomplished
11/10/2021 19:06
Oct 11 (Reuters) - Nymox Pharmaceutical Corp NYMX.O :
* NYMOX PHARMACEUTICAL- MAIN DELAYED VENDOR DOCUMENTATION
THAT WAS
INCOMPLETE HAS BEEN ACCOMPLISHED
* NYMOX PHARMACEUTICAL - REINFORCES COMPLETION TASKS FOR
IMPORTANT
FEXAPOTIDE FILING HAVE ADVANCED AS ANTICIPATED
Source text for Eikon: ID:nGNX6XgDMq
Further company coverage: NYMX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Nymox Pharmaceutical
See all newsBrief: Nymox Says Required To Resubmit Application To DKMA
Brief: Nymox Pharmaceutical Corp Says Terminated Employment Of Christopher R Riley As CFO (June 27)
Brief: Nymox Announces Appointment Of Christopher R. Riley As Chief Financial Officer
Brief: Nymox Appeals Deficiency Letter
U.S. STOCKS ON THE MOVE-Pot stocks, Nymox, Zynerba